Monopar Therapeutics Signs On at Rosalind Franklin University’s Helix 51 Incubator

We’re excited to welcome Monopar Therapeutics Inc. to the Rosalind Franklin University of Medicine and Science Helix 51 biomedical incubator! Monopar is the latest thriving biotech company to sign on at the incubator, which provides cutting-edge lab space and technology, a deep bench of talent, and other resources to nurture research and support transformative healthcare opportunities.

“We are excited to be a part of the vibrant biomedical community at RFU,” says Monopar COO Andrew Cittadine. “We see this as an opportunity to accelerate the development of new products and were drawn to the talented and collaborative community at Helix 51.” Helix 51 is the premier wet-and dry-lab based incubator in Lake County, and it provides the research space and essentials that growing biotech and biopharma companies need to develop drugs and devices and advance research and development.

Click here to learn more.